The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s benign prostatic hyperplasia (BPH) treatment devices and equipment market report forecasts the benign prostatic hyperplasia (BPH) treatment devices and equipment market size to grow to $2.09 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report 2023 –
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size Forecast
The global benign prostatic hyperplasia (BPH) treatment devices and equipment market is expected to grow from $1.49 billion in 2022 to $1.62 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global benign prostatic hyperplasia (BPH) market size is expected to grow to $2.09 billion in 2027 at a CAGR of 6.6%.

North America held the largest benign prostatic hyperplasia (BPH) treatment devices and equipment market share.

Key Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Driver ­– Increase In Number Of BPH Cases Increases The Demand For Devices
For example, in 2021, more than 14 million men in the United States have symptoms of BPH. Globally 30 million men have symptoms related to BPH. Therefore, with the number of BPH cases on the steady rise, the demand for BPH treatment devices and equipment is also expected to grow.

Request for A Sample Of The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Key Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trend – Developing Prostatic Artery Embolization
PAE is a minimally invasive treatment that assists in reducing the symptoms observed in the urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complications in the treatment of BPH and thus is said to be a major development in the market of BPH treatment. Leading companies such as Boston scientific, UNC healthcare, and Spire healthcare have been investing in the market for PAE.

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Segment

1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants

2) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

3) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Major Players and Strategies
Major players in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are Karl Storz, Lumenis, Olympus, Urologix, Boston Scientific Inc., Endo International, Neo tract, Lisa Laser, Medifocus Inc., ProArc Medical LTD., and Olympus America.

In March 2021, Olympus exercises, a Japan-based company manufacturer of optics and reprography products acquired Medi-Tate for an undisclosed amount. This acquisition of Medi-Tate to drive growth in its urology business and expand its minimally invasive treatment product portfolio. Medi-Tate is an Israeli medical device company for improves men’s healthcare and quality of life through effective, non-surgical solutions.

The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023 covers regional data on benign prostatic hyperplasia (BPH) treatment devices and equipment market size, benign prostatic hyperplasia (BPH) treatment devices and equipment market trends and drivers, opportunities, strategies, and benign prostatic hyperplasia (BPH) treatment devices and equipment market competitor analysis. The countries covered in the benign prostatic hyperplasia (BPH) treatment devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of prostate gland enlargement which causes blockade of urethra, the tube that carries urine from the bladder.

View More Reports Related To The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market –

Tumor Ablation Therapy Devices Global Market Report 2022

Intracranial Stents Global Market Report 2022

Medical Equipment Global Market Report 2022

Email us at [email protected]

Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Follow us on:

LinkedIn: https://bit.ly/3WzV8lZ

YouTube: https://bit.ly/3jiemhz

Global Market Model: https://bit.ly/3Was30B